相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MED12 exon 2 mutations are common in uterine leiomyomas from South African patients
Netta Mäkinen et al.
Oncotarget (2015)
Morphologic and Molecular Characteristics of Uterine Leiomyomas in Hereditary Leiomyomatosis and Renal Cancer (HLRCC) Syndrome
Julian Sanz-Ortega et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer
K. Kampjarvi et al.
BRITISH JOURNAL OF CANCER (2012)
Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors
Eun Mi Je et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
MED12 mutations in uterine fibroids-their relationship to cytogenetic subgroups
Dominique Nadine Markowski et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Whole Exome Sequencing in a Random Sample of North American Women with Leiomyomas Identifies MED12 Mutations in Majority of Uterine Leiomyomas
Megan M. McGuire et al.
PLOS ONE (2012)
MED12 Alterations in Both Human Benign and Malignant Uterine Soft Tissue Tumors
Gaelle Perot et al.
PLOS ONE (2012)
Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics
Heli J. Lehtonen
FAMILIAL CANCER (2011)
MED12, the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas
Netta Makinen et al.
SCIENCE (2011)
The human Mediator complex: a versatile, genome-wide regulator of transcription
Dylan J. Taatjes
TRENDS IN BIOCHEMICAL SCIENCES (2010)
The Human CDK8 Subcomplex Is a Histone Kinase That Requires Med12 for Activity and Can Function Independently of Mediator
Matthew T. Knuesel et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Association of Germline Mutations in the Fumarate Hydratase Gene and Uterine Fibroids in Women With Hereditary Leiomyomatosis and Renal Cell Cancer
Laveta Stewart et al.
ARCHIVES OF DERMATOLOGY (2008)
Etiology, symptomatology, and diagnosis of uterine myomas
William H. Parker
FERTILITY AND STERILITY (2007)
Annual costs associated with diagnosis of uterine leiomyornata
Katherine E. Hartmann et al.
OBSTETRICS AND GYNECOLOGY (2006)
Health care resource use for uterine fibroid tumors in the United States
Michael Flynn et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
Mediator is a transducer of Wnt/β-catenin signaling
Seokjoong Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer
MH Wei et al.
JOURNAL OF MEDICAL GENETICS (2006)
Increased risk of cancer in patients with fumarate hydratase germline mutation
H. J. Lehtonen et al.
JOURNAL OF MEDICAL GENETICS (2006)
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyoma
AA Sandberg
CANCER GENETICS AND CYTOGENETICS (2005)
Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors
R Lehtonen et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
HMGA2 expression in uterine leiomyomata and myometrium:: Quantitative analysis and tissue culture studies
KL Gross et al.
GENES CHROMOSOMES & CANCER (2003)
High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence
DD Baird et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer
IPM Tomlinson et al.
NATURE GENETICS (2002)
Inherited susceptibility to uterine leiomyomas and renal cell cancer
V Launonen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes
G Tallini et al.
LABORATORY INVESTIGATION (2000)
分享论文
